We are live on
!
Find out more
AL
Airain Ltd Portfolio holdings
AUM
$2.26B
1-Year Est. Return
12.43%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+12.43%
3 Year Est. Return
-0.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
-$215M
(-13%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-12.71%
Top 10 Holdings %
Top 10 Hldgs %
13.94%
Holding
1,266
New
445
Increased
181
Reduced
178
Closed
459
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PMC
PharMerica Corporation
PMC
|
+$37.9M |
| 2 |
SLB Ltd
SLB
|
+$16.1M |
| 3 |
Apple
AAPL
|
+$16.1M |
| 4 |
Phillips 66
PSX
|
+$13.5M |
| 5 |
PRE
PARTNERRE LTD
PRE
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$16.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$14M |
| 3 |
CVS Health
CVS
|
+$13.5M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$11.5M |
| 5 |
Qualcomm
QCOM
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.66% |
| 2 | Industrials | 13.26% |
| 3 | Healthcare | 12.83% |
| 4 | Financials | 12.32% |
| 5 | Energy | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Pacira BioSciences
PCRX
$1.02B
| $281K | 0.02% |
3,655
-2,040
| -36% | -$116K |
|
627
AstraZeneca
AZN
$263B
| $280K | 0.02% |
+4,118
| New | +$270K |
|
628
Prestige Consumer Healthcare
PBH
$2.35B
| $280K | 0.02% |
+5,444
| New | +$270K |
|
629
Mondelez International
MDLZ
$77.7B
| $279K | 0.02% |
+6,229
| New | +$279K |
|
630
Comfort Systems
FIX
$61B
| $278K | 0.02% |
+9,766
| New | +$297K |
|
|
JUNO
631
DELISTED
Juno Therapeutics, Inc.
JUNO
| $278K | 0.02% |
+6,321
| New | +$313K |
|
632
Enviri
NVRI
$621M
| $277K | 0.02% |
35,111
+16,294
| +87% | +$159K |
|
633
Credit Acceptance
CACC
$6B
| $276K | 0.02% |
+1,288
| New | +$263K |
|
|
WUBA
634
DELISTED
58.com Inc
WUBA
| $276K | 0.02% |
+4,191
| New | +$236K |
|
635
Manhattan Associates
MANH
$8.97B
| $275K | 0.02% |
+4,163
| New | +$296K |
|
|
WRK
636
DELISTED
WestRock Company
WRK
| $275K | 0.02% |
6,695
-119,729
| -95% | -$5.45M |
|
|
NTRI
637
DELISTED
NutriSystem, Inc.
NTRI
| $275K | 0.02% |
+12,709
| New | +$300K |
|
638
Archrock
AROC
$6.33B
| $274K | 0.02% |
+36,449
| New | +$521K |
|
639
Banner Corp
BANR
$2.39B
| $274K | 0.02% |
+5,972
| New | +$295K |
|
640
Kirby Corp
KEX
$7.95B
| $274K | 0.02% |
+5,199
| New | +$322K |
|
|
LTRPA
641
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $274K | 0.02% |
9,025
-31,407
| -78% | -$926K |
|
642
Tidewater
TDW
$3.91B
| $273K | 0.02% |
1,218
-1,422
| -54% | -$501K |
|
|
AJRD
643
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $272K | 0.02% |
+17,372
| New | +$290K |
|
644
Corning
GLW
$126B
| $271K | 0.02% |
14,820
-506,895
| -97% | -$9.19M |
|
|
KRA
645
DELISTED
Kraton Corporation
KRA
| $271K | 0.02% |
+16,310
| New | +$334K |
|
|
CKH
646
DELISTED
Seacor Holdings Inc.
CKH
| $269K | 0.02% |
+5,284
| New | +$294K |
|
|
RGLS
647
DELISTED
Regulus Therapeutics
RGLS
| $268K | 0.02% |
+256
| New | +$257K |
|
|
MDR
648
DELISTED
McDermott International
MDR
| $268K | 0.02% |
26,624
-20,143
| -43% | -$276K |
|
|
HPY
649
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $267K | 0.02% |
+2,812
| New | +$217K |
|
|
MDVN
650
DELISTED
MEDIVATION, INC.
MDVN
| $267K | 0.02% |
5,532
-187,149
| -97% | -$8.07M |
|
Similar funds
HCM
TCM
AT
RBC
DL
VKH
CAM
1GA
Airain Ltd's Q4 2015 Portfolio in Review
As of Q4 2015, Airain Ltd held 1,266 positions worth $1.45B, down 13% from $1.67B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Airain Ltd withdrew a net $185M in Q4 2015, closing 459 positions and reducing 178 holdings. Its most notable exit was Abbott, an estimated $16.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Airain Ltd opened a new position in SLB Ltd worth $15M.
- Airain Ltd's largest Q4 2015 buy was SLB Ltd: 215,437 shares worth $15M.
- Airain Ltd added most to PharMerica Corporation in Q4 2015, an estimated $37.9M increase.
- Airain Ltd's biggest Q4 2015 reduction was Teva Pharmaceuticals, cutting an estimated $14M.
- Airain Ltd fully exited Abbott in Q4 2015, selling an estimated $16.4M.
- Airain Ltd's ten largest holdings make up 14% of its $1.45B portfolio in Q4 2015.
- Airain Ltd opened 445 new positions and closed 459 in Q4 2015.
- Airain Ltd's portfolio value fell 13% quarter-over-quarter to $1.45B.
Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.